The very first asymmetric full synthesis of conolidine was developed by Micalizio and coworkers in 2011.[2] This artificial route allows entry to both enantiomer (mirror impression) of conolidine through an early enzymatic resolution. "We confirmed that conolidine binds on the newly recognized opioid receptor ACKR3, whilst displaying no affinity https://keikoz691xtp9.oneworldwiki.com/user